“Most men with early-stage prostate cancer will die with their disease, not from their disease,” Dr Murphy said. Partial gland ablation of MRI-invisible prostate cancer has been controversial. Partial ...
Effect of undetectable PSA following SRT for biochemical recurrence on BPFS, FFM, and OS. Short term pathologic outcomes and biochemical recurrence rates of single port transvesical retzius-sparing ...
Vascular-targeted photodynamic therapy continues to shows efficacy for partial gland ablation of intermediate-risk prostate cancer with minimal toxicity, according to long-term follow-up results from ...
Single-fraction high-dose-rate (HDR) brachytherapy boost and hypofractionated radiation for intermediate- and high-risk prostate cancer: A report of toxicity from a single center experience.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results